MAJOR ANTIGENIC DOMAIN RECOGNIZED BY MONOCLONAL-ANTIBODIES MAPS WITHIN THE CARBOXY-TERMINAL MOIETY OF A RECOMBINANT HUMAN IMMUNODEFICIENCY VIRUS-1 P24 PROTEIN

被引:2
|
作者
GALLINA, A
ROSSI, F
MARIANI, M
BONELLI, F
ACHILLI, G
CATTANEO, E
MILANESI, G
机构
[1] CNR, IST GENET BIOCHIM & EVOLUZ, VIA ABBIATEGRASSO 207, I-27100 PAVIA, ITALY
[2] SORIN BIOMED SPA, SALUGGIA, ITALY
[3] POLICLIN SAN MATTEO, INST CLIN MALATTIE INFETT, SAN MATTEO, ITALY
关键词
epitope mapping; human immunodeficiency virus; monoclonal antibodies; p24;
D O I
10.1002/jmv.1890320307
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antigenicity in mice of a recombinant polypeptide including the complete amino acid sequence of mature human immunodeficiency virus type 1 p24 protein was studied by induction of monoclonal antibodies (MAbs). A panel of nine recloned hybridomas secreting MAbs with anti‐p24 reactivity was isolated and further characterized. Competitive inhibition experiments suggested that the MAbs could be grouped into four epitopic classes corresponding to at least two distinct determinants. Analysis of reactivity to recombinant p24 deletion variants indicated that all the recognized epitopes are localized within a carboxy‐terminal domain (amino acids 168–208) which should be largely exposed in recombinant as well as authentic antigen. Lack of response to N‐terminal and central portions of p24 suggests that the antigenicity of those regions in the natural polypeptide is strongly conformation‐dependent. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:164 / 170
页数:7
相关论文
共 25 条
  • [21] IMMUNE-RESPONSES TO A 104-MER SYNTHETIC PEPTIDE OF THE INTERNAL MAJOR PROTEIN, GAG (P24) OF THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1)
    SIA, DY
    MASCAGNI, P
    COATES, A
    GIBBONS, W
    VACCINES FOR SEXUALLY TRANSMITTED DISEASES, 1989, : 275 - 280
  • [22] A serological screening assay of human immunodeficiency virus type 1 antibodies based on recombinant protein p24-gp41 as a fusion protein expressed in Escherichia coli
    Mahboudi, Fereidoun
    Irina, Nickolaeva A.
    Chevalier, Alexander
    Ghadiri, Ataallah
    Adeli, Ahmad
    Amini-Bavil-Olyaee, Samad
    Barkhordari, Farzaneh
    Farzamfar, Bardia
    Alinejad, Mahtab
    JOURNAL OF BIOTECHNOLOGY, 2006, 125 (02) : 295 - 303
  • [23] MONOCLONAL-ANTIBODIES AGAINST HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS (HTLV) P24 INTERNAL CORE PROTEIN - RECOGNITION OF HTLVI AND HTLVII INFECTED T-CELLS AND CELLULAR-LOCALIZATION OF HTLV
    PALKER, TJ
    SCEARCE, RM
    POPOVIC, M
    GALLO, RC
    BOLOGNESI, DP
    HAYNES, BF
    CLINICAL RESEARCH, 1984, 32 (02): : A421 - A421
  • [24] INSERTION OF A SHORT HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-2 GP36 SEQUENCE INTO AN HIV-1 P24 RECOMBINANT PROTEIN RESULTS IN A POLYPEPTIDE WITH POTENT AND TCRBV-RESTRICTED T-CELL TRIGGERING ACTIVITY
    IMBERTI, L
    SOTTINI, A
    ROLDAN, EQ
    ALBERTINI, A
    MATTIOLI, S
    PRATI, E
    PRIMI, D
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (01) : 218 - 225
  • [25] IN-VIVO INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC CYTOTOXIC T-LYMPHOCYTES AND DELAYED-TYPE HYPERSENSITIVITY BY A 23-AMINO ACID PEPTIDE FROM THE HIGHLY CONSERVED REGION IN MAJOR CORE PROTEIN P24
    NISHINO, Y
    KAMEOKA, M
    OKADA, Y
    ZHONG, Q
    KIMURA, T
    AZUMA, I
    IKUTA, K
    VACCINE, 1994, 12 (06) : 485 - 491